Mount Sinai Develops Nanotechnology-Based Immunotherapy Promoting Transplant Acceptance

Article The nano-immunotherapy directly targets myeloid cells without affecting T-cells, and inhibits trained immunity. Contributed Author: The Mount Sinai Hospital/Mount SInai School of Medicine Topics: Surgical Products